PHIO PHARMACEUTICALS CORP. Restricted Cash and Cash Equivalents
PHIO PHARMACEUTICALS CORP. (PHIO) had Restricted Cash and Cash Equivalents of $50.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-26.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2018-03-26
- 2017-12-31: Restricted Cash and Cash Equivalents $50.00K.
- 2017-09-30: Restricted Cash and Cash Equivalents $50.00K.
- 2017-06-30: Restricted Cash and Cash Equivalents $50.00K.
- 2017-03-31: Restricted Cash and Cash Equivalents $50.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2017-12-31 | $50.00K 10-K · filed 2018-03-26 |
| 2017-09-30 | $50.00K 10-Q/A · filed 2018-03-26 |
| 2017-06-30 | $50.00K 10-Q/A · filed 2018-03-26 |
| 2017-03-31 | $50.00K 10-Q/A · filed 2018-03-26 |
| 2016-12-31 | $50.00K 10-Q/A · filed 2018-03-26 |
| 2016-09-30 | $50.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $50.00K 10-Q/A · filed 2018-03-26 |
| 2016-03-31 | $50.00K 10-Q/A · filed 2018-03-26 |
| 2015-12-31 | $50.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $50.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $50.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $50.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $50.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $50.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $50.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $50.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $50.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $53.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $53.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $53.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $53.00K 10-K · filed 2014-03-28 |
| 2012-09-30 | $53.00K 10-Q · filed 2012-11-13 |
| 2011-12-31 | $53.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |